SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-24-012793
Filing Date
2024-04-11
Accepted
2024-04-11 16:35:59
Documents
2
Period of Report
2024-04-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1423
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 3055
  Complete submission text file 0001127602-24-012793.txt   5921
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Issuer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address
Cornelissen Bart Jan (Reporting) CIK: 0002018934 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36182 | Film No.: 24838933